Form D · Other Technology

Primary Bioscience, Inc.

Seattle, WA · CIK 0002012695

Offering snapshot reported Jun 23, 2026 · SEC filing

Reported sold
$1.3M
Offering amount: $1.8M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 2, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$650K$1.3MOct 7, 2025: $100,000.00Oct 7, 2025Oct 24, 2025: $1,100,000.00Jun 23, 2026: $1,300,000.00Jun 23, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,100,000 → $1,300,000
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 23, 2026Amendment$1,300,000$200,000vs Oct 24, 20253SEC filing
Oct 24, 2025Amendment$1,100,000$1,000,000vs Oct 7, 20252SEC filing
Oct 7, 2025Initial$100,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-560014

Source: Form D, filed Jun 23, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stacy Anderson Director, Executive, Promoter

Issuer details

Industry: Other Technology (See others in industry)

Address:
7335 14 Th Ave Nw
Seattle, WA, 98117